Horsham: Johnson & Johnson has announced that the Company ahs received approval from the U.S. Food and Drug Administration ...
With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...
Johnson & Johnson's nipocalimab receives FDA Fast Track status for Sjögren's disease, following strong Phase 2 trial results ...
The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press ...
Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...
The Tennessee Senate Energy, Agriculture and Natural Resources Committee killed a bill that would require state water systems ...
Spring House, Pennsylvania Wednesday, March 19, 2025, 14:00 Hrs [IST] ...
Switching to IMVT-1402 extends the head starts Immunovant has already ceded to its rivals. Argenx won FDA approval for ...
FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to-severe Sjögren’s disease, which could be the first targeted therapy ever ...
A new look for Cruisin’ the Chisholm Trail Car and Motorcycle Show will come to Main Street Duncan April 5. With a weekend packed full of events, car enthusiasts will get the opportunity to take a ...
House: Johnson & Johnson has received Fast Track designation (FTD) from the U.S. Food and Drug Administration (FDA) for ...
As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback